The National Academy of Medicine of Venezuela reiterates these remarks on the alert that pharmacists who are on duty in Cuba “do not have vacancies” against covid-19, “its experimental products”, see a president President Nicolás Maduro announced that one of them is produced in the country.
“We have been alerted that Cuban products do not have vacancies, their experimental products of these species do not know their composition, security, or efficiency”, said a statement from the Academy.
Last week, Maduro announced that Venezuela would produce at least 2 million Abdalá, one of the Cuban vaccine projects against covid-19, after reiterating that it had signed an agreement with the Caribbean to manufacture pharmacies.
“We have signed an agreement to produce in our laboratories (…) 2 million vacancies per month of the Abdalá vacancy, and for them for the months of August, September, approximately”, the governor said.
It also ensures that the company enters into agreements with China, Russia and other countries to produce vehicles against the covid-19.
Respectively, the Academy submits that “there is an urgent need to have a national evacuation plan against covid-19, which will serve as a fundamental support for all initiatives that need to complete the immunization of an estimated 15 million of Venezuelans “.
At present, Venezuela has 250,000 doses of the Russian Sputnik-V vaccine and 500,000 Chinese Sinopharm, informant Brindada van el Gobierno that monkeys have facilitated data on respect, with which they are counted from those who have not been inoculated.
The units are currently receiving double-dose allotments, only to increase to 1.3% of the population, close to 30 million residents, including the Minister of Health, Carlos Alvarado, the rapid-fire march, something that does not frame the real numbers.
On the other hand, Maduro announced the domingo that the Executive has agreed to release funds, that EE.UU. tenia “secuestrados” debited the international sanctions, sufficient to acquire 11,374,400 vacancies of the Covax mechanism, although the Gobierno returns the AstraZeneca formula, which initially initiated the tenia system in Venezuela.
For the Academy, “it represents a step in the appropriate direction”, but it is clear that “it is not sufficient”, by which, in its judgment, “the national advertisement” for the vacancies “should continue until every Venezuelan is elected vacant. “.
Asimismo, announces that the announcement is “without the knowledge of the Mesa Técnica Nacional for access to Covax”, integrated by the Ministry for Health, opponents, representatives of the National Academy of Medicine and Scientific Organizations, de la Salud y de Unicef.
Respectively, we can also subscribe to the information that has been generated by this announcement, the first of which is the lack of information “about which will be the vacancy that will be acquired, when the exile will be in Venezuela”.